Your browser doesn't support javascript.
loading
Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept.
Guermazi, Dorra; Arvanitis, Panos; Farmakiotis, Dimitrios.
Afiliação
  • Guermazi D; Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Gerry House 111, Providence, RI, 02903, USA.
  • Arvanitis P; Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Gerry House 111, Providence, RI, 02903, USA.
  • Farmakiotis D; Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Gerry House 111, Providence, RI, 02903, USA. dimitrios.farmakiotis@lifespan.org.
Infection ; 51(5): 1593-1595, 2023 10.
Article em En | MEDLINE | ID: mdl-37004695

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article